Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Bionano Genomics stock

Learn how to easily invest in Bionano Genomics stock.

Bionano Genomics is a medical instruments & supplies business based in the US. Bionano Genomics shares (BNGO) are listed on the NASDAQ and all prices are listed in US Dollars. Bionano Genomics employs 299 staff and has a trailing 12-month revenue of around $25.9 million.

How to buy Bionano Genomics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – BNGO. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Bionano Genomics stock price (NASDAQ: BNGO)

Use our graph to track the performance of BNGO stocks over time.

Bionano Genomics shares at a glance

Information last updated 2023-01-25.
Latest market close$1.85
52-week range$1.16 - $4.35
50-day moving average $1.95
200-day moving average $1.98
Wall St. target price$6.70
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.33

Buy Bionano Genomics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Bionano Genomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bionano Genomics price performance over time

Historical closes compared with the close of $1.85 from 2023-01-27

1 week (2023-01-23) -3.65%
1 month (2022-12-30) 26.71%
3 months (2022-10-27) -13.35%
6 months (2022-07-26) 9.47%
1 year (2022-01-28) -4.64%
2 years (2021-01-29) -83.26%
3 years (2020-01-30) 69.72%
5 years (2018-01-26) N/A

Bionano Genomics financials

Revenue TTM $25.9 million
Gross profit TTM $3.9 million
Return on assets TTM -22.17%
Return on equity TTM -37.5%
Profit margin 0%
Book value $0.95
Market capitalisation $546.3 million

TTM: trailing 12 months

Bionano Genomics share dividends

We're not expecting Bionano Genomics to pay a dividend over the next 12 months.

Bionano Genomics share price volatility

Over the last 12 months, Bionano Genomics's shares have ranged in value from as little as $1.16 up to $4.35. A popular way to gauge a stock's volatility is its "beta".

BNGO.US volatility(beta: 2.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionano Genomics's is 2.2531. This would suggest that Bionano Genomics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Bionano Genomics overview

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California. .

Frequently asked questions

What percentage of Bionano Genomics is owned by insiders or institutions?
Currently 1.869% of Bionano Genomics shares are held by insiders and 27.604% by institutions.
How many people work for Bionano Genomics?
Latest data suggests 299 work at Bionano Genomics.
When does the fiscal year end for Bionano Genomics?
Bionano Genomics's fiscal year ends in December.
Where is Bionano Genomics based?
Bionano Genomics's address is: 9540 Towne Centre Drive, San Diego, CA, United States, 92121
What is Bionano Genomics's ISIN number?
Bionano Genomics's international securities identification number is: US09075F1075
What is Bionano Genomics's CUSIP number?
Bionano Genomics's Committee on Uniform Securities Identification Procedures number is: 09075F206

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site